Nicox S.A.
Ophthalmology company developing therapies based on a nitric oxide-donating platform.
COX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013018124 (+6 more)
- LEI:
- 969500EZGEO9W4JXR353
- Country:
- France
- Address:
- SOPHIA, 06410 BIOT
- Website:
- https://www.nicox.com/
Description
Nicox S.A. is an international ophthalmology company focused on the research and development of innovative therapeutic solutions to maintain vision and improve ocular health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost analog in late-stage clinical development for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Nicox's pipeline is based on its proprietary NO-donating research platform. The company has also developed two approved ophthalmic products: VYZULTA® (latanoprostene bunod ophthalmic solution), licensed exclusively to Bausch + Lomb, and ZERVIATE® (cetirizine ophthalmic solution), licensed to various partners for commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-30 07:30 |
Nicox annonce le lancement d’une augmentation de capital avec maintien du droit…
|
French | 276.7 KB | ||
| 2024-05-24 07:30 |
Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024
|
English | 89.5 KB | ||
| 2024-05-24 07:30 |
Nicox : Assemblée Générale Ordinaire le 28 juin 2024
|
French | 89.7 KB | ||
| 2024-05-06 17:46 |
Nicox’s Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024
|
English | 98.3 KB | ||
| 2024-05-06 17:46 |
Nicox : assemblée générale ordinaire et extraordinaire du 6 mai 2024
|
French | 104.3 KB | ||
| 2024-05-02 17:45 |
Number of voting rights as of April 30, 2024
|
English | 83.7 KB | ||
| 2024-05-02 17:45 |
Nombre de droits de vote au 30 avril 2024
|
French | 76.1 KB | ||
| 2024-04-24 07:30 |
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on…
|
English | 104.9 KB | ||
| 2024-04-24 07:30 |
Nicox : Deuxième convocation à l’Assemblée Générale Ordinaire et Extraordinaire…
|
French | 108.6 KB | ||
| 2024-04-09 17:30 |
Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024
|
French | 91.4 KB | ||
| 2024-04-09 17:30 |
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
|
English | 69.5 KB | ||
| 2024-04-02 17:45 |
Nombre de droits de vote au 31 mars 2024
|
French | 75.6 KB | ||
| 2024-04-02 17:45 |
Number of voting rights as of March 31, 2024
|
English | 75.1 KB | ||
| 2024-03-22 07:30 |
Nicox - Lettre aux Actionnaires
|
French | 185.4 KB | ||
| 2024-03-22 07:30 |
Nicox's Shareholder Letter
|
English | 182.2 KB |
Automate Your Workflow. Get a real-time feed of all Nicox S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nicox S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nicox S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
